reglab/statecodes huggingface dataset:
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.06 - Residential Service - Clinically Managed Low Intensity Treatment Level III.1

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description. Clinically managed low intensity treatment programs shall offer
				  treatment services at least 5 hours a week directed toward preventing relapse,
				  applying recovery skills, promoting personal responsibility, and
				  reintegration.
B. Patients who are
				  appropriate for this level of treatment shall:
(1) Meet the current edition of the American
				  Society of Addiction Medicine Patient Placement Criteria for Level III.1, or
				  its equivalent as approved by the Administration; and
(2) Be capable of self-care but not ready to
				  return to family or independent living.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.07 - Residential Services - Clinically Managed Medium Intensity Treatment Level III.3

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description. A clinically managed medium intensity treatment program provides a
				  structured environment in combination with medium intensity treatment and
				  ancillary services to support and promote recovery.
B. Patients who are appropriate for this
				  level of treatment:
(1) Meet the current
				  edition of the American Society of Addiction Medicine Patient Placement
				  Criteria for Level III.3, or its equivalent as approved by the
				  Administration;
(2) Are chronic
				  alcohol or other drug dependent individuals;
(3) Do not need skilled nursing
				  care;
(4) May have a history of
				  multiple admissions to alcohol or drug abuse or dependence programs as defined
				  in COMAR 10.47.01;
(5) May have
				  physical and mental disabilities as a result of prolonged alcohol or other drug
				  use; and
(6) Have been identified
				  as individuals for whom a controlled environment and supportive therapy are
				  necessary for an indefinite period of time.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.08 - Residential Services - Clinically Managed High Intensity Treatment Level III.5

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description. A clinically managed high intensity residential program shall:
(1) Provide a highly structured environment
				  in combination with moderate to high intensity treatment and ancillary services
				  to support and promote recovery; and
(2) Be characterized by its reliance on the
				  treatment community as a therapeutic agent.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.09 - Residential Services - Medically Monitored Intensive Inpatient Treatment Level III.7

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description. A medically monitored intensive inpatient treatment program shall:
(1) Offer a planned regimen of 24-hour
				  professionally directed evaluation, care, and treatment in an inpatient
				  setting;
(2) Act as an Intermediate
				  Care Facility Type C/D; and
(3)
				  Meet the certification requirements for detoxification services as described in
				  COMAR 10.47.02.10E.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.10 - Detoxification Services

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Description of Services. A detoxification program shall provide services to an
				  intoxicated patient by:
(1) Monitoring the
				  decreasing amount of psychoactive substances in the body;
(2) Managing the withdrawal symptoms;
				  and
(3) Motivating the individual
				  to participate in an appropriate treatment program for alcohol or other drug
				  dependence.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.02 - Specific Program Requirements › Section 10.47.02.11 - Opioid Maintenance Therapy

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Program Description. Opioid maintenance therapy:
(1) Uses pharmacological interventions,
				  including full and partial opiate agonist treatment medications, to provide
				  treatment, support, and recovery to opioid-addicted patients;
(2) Is a separate service that is certified
				  and offered by a program as described in COMAR 10.47.02.03-.11;
(3) Complies with the requirements under this
				  regulation; and
(4) Can be provided
				  in correctional facility based programs.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
A. This chapter
				  sets forth:
(1) Additional requirements that
				  a program shall meet to be certified to offer the correctional levels of care;
				  and
(2) Requirement exemptions for
				  a program certified as a correctional level of care, which shall meet the
				  requirements of COMAR 10.47.01 and 10.47.04.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
In this chapter, terms have the meanings stated in COMAR
					 10.47.01.02A.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.03 - Correctional Level I

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description.
(1) The program shall provide
				  evaluation and treatment to patients who require services for less than 9 hours
				  weekly in a correctional facility.
(2) Inmates receiving treatment may be housed
				  throughout the correctional facility.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.04 - Correctional Level II.1

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description.
(1) A program shall provide
				  structured evaluation and treatment to patients who require services from 9 to
				  20 hours weekly in a correctional facility.
(2) Inmates receiving treatment may be housed
				  throughout the institution.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.05 - Correctional Level II.5

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description.
(1) A program shall provide
				  structured evaluation and treatment to patients who require programming from 20
				  to 35 hours weekly in a correctional facility.
(2) Inmates receiving treatment may be housed
				  together in a separate unit.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.06 - Correctional Level III.1

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description.
(1) A program shall offer
				  treatment services at least 5 hours a week directed toward preventing relapse,
				  applying recovery skills, promoting personal responsibility, and reintegration
				  into the community.
(2) Inmates
				  receiving this level of treatment shall be housed:
(a) Together in a prerelease center or a
				  correctional halfway house; and
(b)
				  Separately from inmates not receiving this level of treatment.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.03 - Specific Program Requirements for Correctional Levels of Care › Section 10.47.03.07 - Correctional Level III.5

Current through Register Vol. 51, No. 14, July 12, 2024
A. Program
				  Description. A correctional Level III.5 program:
(1) Shall provide a highly structured
				  environment in combination with moderate to high intensity treatment and
				  ancillary services to support and promote recovery;
(2) Shall be characterized by its reliance on
				  the treatment community as a therapeutic agent; and
(3) May not allow a structure whereby inmates
				  have authority over one another.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter sets forth additional requirements that a
					 program shall meet to be certified to offer a particular level of treatment.
					 The program shall meet the requirements of COMAR 10.47.01 and this
					 chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  terms have the meanings stated in COMAR
				  10.47.01.02A.
B. In addition to terms referenced
				  under §A of this regulation, in this chapter the following terms have the
				  meanings indicated.
C. Terms
				  Defined.
(1) "Deficiency" means a failure to
				  meet a regulation or its intent.
(2) "Plan of correction" means the program's
				  proposed response to findings of noncompliance identified by the Office of
				  Health Care Quality or the Administration.
(3) "Sale" means the transfer of a majority
				  interest of ownership.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.03 - Certification Required

Current through Register Vol. 51, No. 14, July 12, 2024
A. All
				  programs and prevention programs shall be certified by the Department before
				  program services and prevention program services may be provided in the
				  State.
B. The following are exempt
				  from certification under this chapter:
(1) A
				  health professional licensed under the Health Occupations Article who is
				  treating patients within the scope of the professional's practice and who does
				  not advertise the practice as an alcohol abuse or drug abuse program;
(2) Alcoholics Anonymous, Narcotics
				  Anonymous, transitional housing programs, or other similar organizations, if
				  the organization holds meetings or provides support services to help
				  individuals who show the effects of drug abuse or alcohol abuse;
(3) An employees' assistance program of a
				  business entity; and
(4) A hospital
				  as defined in Health-General Article, §19-301, Annotated Code of Maryland,
				  accredited by the Joint Commission on Accreditation of Health Care
				  Organizations with a separately accredited alcohol and drug abuse
				  program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.04 - Type and Duration of Certification

Current through Register Vol. 51, No. 14, July 12, 2024
A. Initial Certification.
(1) After receipt of the completed written or
				  electronic application provided by the Administration and after inspection by
				  the Office of Health Care Quality, if there are no deficiencies, the
				  Administration shall grant an initial certification.
(2) The initial certification is valid for a
				  period in the discretion of the Administration, not to exceed 6
				  months.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.05 - Application Process and Evaluation

Current through Register Vol. 51, No. 14, July 12, 2024
A. Application. An applicant for
				  certification of a program or renewal of certification shall submit to the
				  Office of Health Care Quality:
(1) A
				  completed application on a written or electronic form approved by the
				  Administration;
(2) Documentation
				  of:
(a) The program service plan;
(b) Satisfactory fire, safety, and health
				  inspection reports; and
(c)
				  Compliance with COMAR 10.47.01 and the applicable specific program requirements
				  under COMAR 10.47.02;
(3) A request for a variance or a waiver of a
				  regulation; and
(4) An application
				  fee of $700 with initial application and at recertification, if the program
				  provides opioid maintenance therapy as described in COMAR 10.47.02.11.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.06 - Waiver and Variances

Current through Register Vol. 51, No. 14, July 12, 2024
A. Upon
				  written request by the program, the Director shall issue a written decision
				  which may:
(1) Grant a variance or waiver
				  from a regulation if the:
(a) Variance or
				  waiver would not endanger the life or safety of a patient in a program;
				  or
(b) Intent of the regulation to
				  which a variance or waiver is sought meets the alternative proposed by the
				  program; or
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.07 - Investigation or Inspection by the Administration or Office of Health Care Quality

Current through Register Vol. 51, No. 14, July 12, 2024
A. A program
				  shall be open at all reasonable times for announced and unannounced inspections
				  or investigations by the Administration or its designees.
B. A program shall be open at all reasonable
				  times for announced and unannounced inspections or investigations by the Office
				  of Health Care Quality.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.04 - Certification Requirements › Section 10.47.04.08 - Denial, Probation, Intermediate Sanctions, Suspension, or Revocation

Current through Register Vol. 51, No. 14, July 12, 2024
A. If an applicant
				  or program fails to comply with the applicable State and federal laws, rules,
				  or regulations, the Director may:
(1) Deny
				  approval to the applicant; or
(2)
				  Take disciplinary action, such as:
(a) Placing
				  the program on probation;
(b)
				  Suspending or revoking the certification of the program; or
(c) Imposing intermediate sanctions on the
				  program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.05 - Education Programs › Section 10.47.05.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter sets forth additional requirements that a
					 program shall meet as a private or public education program for individuals
					 convicted under Transportation Article, §
										21-902, Annotated Code
					 of Maryland, and ordered to attend an education program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.05 - Education Programs › Section 10.47.05.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
In this chapter, terms have the meanings set forth in COMAR
					 10.47.01.02A.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.05 - Education Programs › Section 10.47.05.03 - Application Process and Evaluation

Current through Register Vol. 51, No. 14, July 12, 2024
A. The applicant shall complete an
				  application on a form approved by the Administration and submit the application
				  and documentation to indicate the applicant is in compliance with the
				  requirements of this chapter.
B.
				  After the Administration receives the application the Administration shall:
(1) Return the application if it is
				  incomplete; or
(2) Arrange a site
				  visit.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.05 - Education Programs › Section 10.47.05.04 - Program Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
The program shall:
A. Comply with COMAR 10.47.01 and
				  10.47.02.03A;
B. At minimum, offer six weekly 2-hour
				  sessions for a total of 12 hours;
C. Have instructors approved by the
				  Administration who are:
(1) Instructors
				  before October 1, 2002; or
(2) At a
				  minimum, certified as a Certified Supervised Counselor-Alcohol and Drug, as
				  defined by Health Occupations Article, Title 17, Annotated Code of
				  Maryland;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.05 - Education Programs › Section 10.47.05.05 - Denial, Probation, Intermediate Sanctions, Suspension, or Revocation

Current through Register Vol. 51, No. 14, July 12, 2024
A. If an applicant
				  or Program fails to comply with the applicable State and federal laws, rules,
				  or regulations, the Director may:
(1) Deny
				  approval to the applicant; or
(2)
				  Take disciplinary action, such as:
(a) Placing
				  the program on probation;
(b)
				  Suspending or revoking the certification of the program; or
(c) Imposing intermediate sanctions on the
				  program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.06 - Substance Abuse Treatment Outcomes Partnerships - (S.T.O.P.) Fund › Section 10.47.06.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter specifies the requirements for applying for
					 funding from the Substance Abuse Treatment Outcomes Partnership Fund. This
					 chapter establishes time lines and procedures for requests for partnership
					 funding, guidelines that require programs to bill third-party insurers, and
					 fund management including, but not limited to, authorization of distribution of
					 money.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.06 - Substance Abuse Treatment Outcomes Partnerships - (S.T.O.P.) Fund › Section 10.47.06.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Department" means the Department of
				  Health and Mental Hygiene.
(2)
				  "Eligiblefunctions"means:
(a) Transportation
				  to and from treatment services;
(b)
				  Treatment, prevention, or coordination staff
(c) Data sharing services among counties and
				  other appropriate treatment providers;
(d) Education or outreach programs and
				  materials;
(e) In-community
				  emergency behavioral health services or crisis stabilization units;
				  or
(f) Behavioral health programs
				  in schools.
(3)
				  "Eligible population" means:
(a) Mothers of
				  drug-addicted infants;
(b) Parents
				  of children in need of assistance;
(c) Hospital emergency room
				  admittees;
(d) Needy families
				  receiving temporary cash assistance;
(e) Foster care children and
				  parents;
(f) Children in
				  after-school programs and their parents, including children and parents in
				  programs supported by the Maryland After-School Opportunity Fund;
(g) Adolescents;
(h) Parents subject to arrearages in child
				  support payments;
(i) Drug
				  offenders under the supervision of the Division of Parole and
				  Probation;
(j) Pretrial
				  correctional inmates;
(k)
				  Prerelease correctional inmates;
(l) The general inmate population within
				  county-managed correctional facilities;
(m) Parents of children entering out-of-home
				  placements or at risk of entering out-of-home placements; or
(n) Drug offenders under the supervision of
				  the problem solving courts.
(4) "Jurisdiction" means Baltimore City or
				  one of the 23 counties in Maryland.
(5) "Partnership funding" means money granted
				  from the Substance Abuse Treatment Outcomes Partnership Fund.
(6) "Proposal" means a plan under this
				  chapter to provide new or expanded substance abuse treatment
				  services.
(7) "Request for partnership funding" means:
(a) A proposal, submitted by the governing
				  bodies of one or more jurisdictions, to provide substance-related disorder
				  treatment services to one or more eligible populations; or
(b) To provide funding for eligible functions
				  within the requesting jurisdiction or jurisdictions.
(8) "Task Force" means the Task Force to
				  Study Increasing the Availability of Substance Abuse Programs.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.06 - Substance Abuse Treatment Outcomes Partnerships - (S.T.O.P.) Fund › Section 10.47.06.03 - Requests for Partnership Funding and Criteria for Awarding Funding

Current through Register Vol. 51, No. 14, July 12, 2024
A. Requests for
				  partnership funding may be submitted to the Department by:
(1) The governing body of a jurisdiction or
				  its designee; or
(2) The governing
				  bodies of more than one jurisdiction or their designee.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.06 - Substance Abuse Treatment Outcomes Partnerships - (S.T.O.P.) Fund › Section 10.47.06.04 - Fiscal Responsibility by Jurisdiction

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Department may award partnership
				  funding that results in a county being responsible for less than 1/2 of the
				  cost of the approved partnership funding after considering:
(1) The financial hardship of the
				  participating county;
(2) Prior and
				  current contributions of funds for substance abuse treatment programs made by
				  the participating county; and
(3)
				  Other relevant considerations considered appropriate by the
				  Department.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter sets forth the requirements for monitoring the
					 prescribing and dispensing of controlled dangerous substances under the
					 Prescription Drug Monitoring Program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.03 - Dispenser Reporting

Current through Register Vol. 51, No. 14, July 12, 2024
A. For each
				  monitored prescription drug and naloxone medication dispensed, the dispenser
				  shall report data elements required by American Society for Automation in
				  Pharmacy (ASAP) standards in addition to the following:
(1) Identifying information for the
				  prescription issued and drug dispensed, including:
(a) Prescription number;
(b) Date prescription was issued;
(c) Date prescription was filled;
(d) Whether the prescription was new or a
				  refill;
(e) Number of refills
				  ordered;
(f) Sources of
				  payment;
(g) National Drug Code for
				  dispensed drug;
(h) Metric quantity
				  of drug dispensed and units;
(i)
				  Days' supply of drug dispensed; and
(j) Date prescription was
				  sold;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.04 - Review of Prescription Monitoring Data

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Program
				  shall review prescription monitoring data and naloxone medication data for
				  indications of possible:
(1) Misuse or abuse
				  of a monitored prescription drug; and
(2) Violations of law or possible breaches of
				  professional standards by a prescriber or a dispenser.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.05 - Disclosure of Naloxone Medication Data

Current through Register Vol. 51, No. 14, July 12, 2024
A. Registration
				  of a Prescriber, a Prescriber Delegate, a Pharmacist, a Pharmacist Delegate, or
				  a Licensed Health Care Practitioner to Request Prescription Monitoring Data.
(1) A prescriber, a prescriber delegate, a
				  pharmacist, a pharmacist delegate, or a licensed health care practitioner shall
				  register with the Department or its agent, in a manner specified by the
				  Department, in order to request disclosure of or otherwise access prescription
				  monitoring data.
(2) The Department
				  or its agent shall:
(a) Establish procedures
				  to authenticate a prescriber, a dispenser, or an authorized licensed health
				  care practitioner in accordance with Health-General Article, §21-2
				  A-06(b)(1)-(2), Annotated Code of Maryland; and
(b) Issue credentials to a prescriber, a
				  prescriber delegate, a pharmacist, or a pharmacist delegate that can be used to
				  request disclosure of or otherwise access prescription monitoring data
				  electronically.
(3) If
				  the credentials issued to a registrant are lost, stolen, or otherwise
				  compromised, the registrant shall notify the Department or its agent, by a
				  method approved by the Department, as soon as reasonably possible.
(4) A prescriber or pharmacist who authorizes
				  the registration of a licensed health care practitioner, prescriber delegate,
				  or pharmacist delegate to request disclosure of or otherwise access
				  prescription monitoring data shall:
(a) Make
				  every reasonable effort, including regularly reviewing and auditing any
				  available logs of system access and use, to ensure the prescriber delegate or
				  pharmacist delegate is requesting disclosure of, redisclosing, or otherwise
				  accessing prescription monitoring data in clear compliance with Health-General
				  Article, Title 21, Subtitle 2A, Annotated Code of Maryland, and all other State
				  and federal laws and regulations governing the security and confidentiality of
				  protected health information and personal medical records;
(b) Immediately notify the Department or its
				  agent, by a method approved by the Department, as well as the licensing entity
				  responsible for licensing, certifying, or registering the prescriber delegate,
				  or pharmacist delegate, if applicable, if the prescriber or pharmacist believes
				  that the confidentiality of prescription monitoring data or the security of the
				  Program has been compromised by that individual; and
(c) Immediately notify the Department or its
				  agent, by a method approved by the Department, of any requested change in the
				  registration status of a licensed health care practitioner, prescriber
				  delegate, or pharmacist delegate, including if that individual is no longer
				  employed by or practicing under the authority of the prescriber or
				  pharmacist.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.05-1 - Disclosure of Naloxone Medication Data

Current through Register Vol. 51, No. 14, July 12, 2024
Disclosure of Naloxone Medication Data for Public Health
					 Surveillance, Research, Analysis, Education, and Public Reporting.
A. The Program shall disclose naloxone
				  medication data for research, analysis, education, and public reporting:
(1) Upon approval by the Department of a
				  written proposal or abstract explaining the purpose and scope of the research,
				  analysis, education, and public reporting; and
(2) After redaction of all information that
				  could identify a patient, prescriber, dispenser, or any other
				  individual.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.06 - Notice to Patients

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Pharmacists.
(1) Any pharmacist who intends
				  to request prescription monitoring data from the Program may post a sign that
				  can be easily viewed by the public at the place where the prescription is
				  delivered to the pharmacist.
(2)
				  The sign shall disclose to the public that the pharmacist may access
				  prescription monitoring data on a patient for whom a prescription for a
				  monitored prescription drug is presented.
(3) In lieu of posting a sign, the pharmacist
				  may provide such notice in written material provided to the patient.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.07 - Confidentiality

Current through Register Vol. 51, No. 14, July 12, 2024
A. Prescription
				  monitoring data and naloxone medication data are confidential, privileged, not
				  subject to discovery, subpoena, or other means of legal compulsion in civil
				  litigation, and are not public records.
B. The Program shall ensure that confidential
				  or privileged patient information be kept confidential and that records or
				  information protected by a privilege between a health care provider and a
				  patient, or otherwise required by law to be held confidential, be filed in a
				  manner that, except as otherwise provided in Health-General Article, §21-2
				  A-06, Annotated Code of Maryland, and Regulation .04 of this chapter, does not
				  disclose the identity of the person protected.
C. The Program shall periodically conduct an
				  audit review of prescription monitoring data and naloxone medication data and
				  disclosure requests to ensure compliance with §B of this
				  regulation.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.08 - Penalties and Sanctions

Current through Register Vol. 51, No. 14, July 12, 2024
A. Civil
				  Penalties. A dispenser who knowingly fails to submit prescription monitoring
				  data or naloxone medication data to the Program as required by Regulation .03
				  of this chapter shall be subject to a civil penalty not exceeding $500 for each
				  failure to submit required information.
B. Criminal Penalties. A person who knowingly
				  discloses, uses, obtains, or attempts to obtain by fraud or deceit prescription
				  monitoring data or naloxone medication data in violation of in Health-General
				  Article, §21-2 A, Annotated Code of Maryland, shall be guilty of a
				  misdemeanor and on conviction is subject to imprisonment not exceeding 1 year
				  or a fine not exceeding $10,000 or both.
C. Administrative Sanctions. A prescriber or
				  pharmacist who knowingly discloses or uses prescription monitoring data or
				  naloxone medication data in violation of Health-General Article, §21-2 A,
				  Annotated Code of Maryland shall be subject to disciplinary action by the
				  appropriate licensing entity.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.07 - Prescription Drug Monitoring Program › Section 10.47.07.09 - General Provisions

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Program
				  shall make available the information technology necessary for dispensers to
				  report prescription monitoring data and naloxone medication data to the
				  Program.
B. The Program may not
				  impose any fees or other assessments on prescribers or dispensers to support
				  the operation of the Program.
C. A
				  prescriber or pharmacist, when acting in good faith, is not subject to
				  liability or disciplinary action arising solely from:
(1) Requesting or receiving prescription monitoring
				  data from the Program; or
(2)
				  Acting, or failing to act, on the basis of prescription monitoring data
				  provided by the Program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter sets forth the requirements for the Overdose
					 Response Program administered by the Department for the purpose of providing a
					 means of training individuals to administer naloxone to an individual
					 experiencing, or believed to be experiencing, opioid overdose to help prevent a
					 fatality when medical services are not immediately available.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Department" means the Department of
				  Health and Mental Hygiene.
(2) "
				  Education and training program" means educational instruction in opioid
				  overdose recognition and response and the administration of naloxone.
(3) "Emergency medical services" means the
				  Statewide comprehensive system of emergency medical care.
(4) "Health care provider" means an
				  individual licensed or certified under Health Occupations Article, Annotated
				  Code of Maryland, or Education Article, §
											13-516, Annotated Code of
				  Maryland, to provide health care services;
(5) "Naloxone" means an opioid antagonist
				  medication used to counter the effects of an opioid overdose.
(6) "Pharmacist" means an individual licensed
				  to practice pharmacy in Maryland under Health Occupations Article, Title 12,
				  Annotated Code of Maryland.
(7)
				  "Private or Public Entity" means a health care provider, local health
				  department, community-based organization, substance use disorder treatment
				  organization, or other person that addresses medical or social issues related
				  to drug addiction.
(8) "Standing
				  order" means a written instruction for the prescribing and dispensing of
				  naloxone in accordance with Health-General Article, Title 13, Subtitle 31,
				  Annotated Code of Maryland.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.03 - Authorization of a Private or Public Entity

Current through Register Vol. 51, No. 14, July 12, 2024
A. Application for Authorization. A private
				  or public entity that seeks to conduct education and training programs under
				  Health-General Article, Title 13, Subtitle 31, Annotated Code of Maryland,
				  shall submit to the Department:
(1) A
				  completed application form containing all identifying information for the
				  private or public entity that is required by the Department, including:
(a) Entity name;
(b) Type of entity based on categories
				  supplied by the Department;
(c)
				  Entity address;
(d) Entity
				  telephone number;
(e)Entity email
				  address;
(f) Name of Entity
				  Director;
(g) Name of Training
				  Program Director; and
(h) Any
				  additional information as requested by the Department;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.04 - Education and Training Programs

Current through Register Vol. 51, No. 14, July 12, 2024
A. A private or public entity authorized by the
				  Department :
(1) Shall offer an education and
				  training program on opioid overdose recognition and response; and
(2) May provide access to naloxone.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.05 - Naloxone Use

Current through Register Vol. 51, No. 14, July 12, 2024
A.
An individual of any age may receive from any health care
					 provider with prescribing authority a prescription for naloxone and the
					 necessary supplies for the administration of naloxone.
B. An individual for whom naloxone is
				  prescribed and dispensed in accordance with this chapter may:
(1) Possess prescribed naloxone and the
				  necessary supplies for the administration of naloxone; and
(2) In an emergency situation when medical
				  services are not immediately available, administer naloxone to an individual
				  experiencing or believed by the individual to be experiencing an opioid
				  overdose.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.06 - Naloxone Prescribing and Dispensing

Current through Register Vol. 51, No. 14, July 12, 2024
A. A healthcare provider with prescribing
				  authority may prescribe and dispense naloxone to an individual of any age who:
(1) Is believed by the health care provider
				  to be at risk of experiencing an opioid overdose; or
(2) Is in a position to assist an individual
				  at risk of experiencing an opioid overdose.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.07 - Denial, Suspension, and Revocation of Authorization of a Private or Public Entity

Current through Register Vol. 51, No. 14, July 12, 2024
A. If the
				  Department determines that a private or public entity has failed to comply with
				  the requirements of this chapter, the Department may initiate one or more of
				  the following actions against the private or public entity:
(1) Denial of an initial application for
				  authorization;
(2) Denial of an
				  application for authorization renewal;
(3) Suspension of the authorization of the
				  private or public entity; or
(4)
				  Revocation of authorization of the private or public entity.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.08 - Appeals

Current through Register Vol. 51, No. 14, July 12, 2024
A private or public entity may request a hearing on an
					 action taken by the Department pursuant to Regulation .07 of this chapter as
					 allowed by:
A. COMAR
				  10.01.03;
B. State Government
				  Article, Title 10, Subtitle 2, Annotated Code of Maryland; and
C. Health-General Article, Title 2, Subtitle
				  2, Annotated Code of Maryland.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.09 - Record Maintenance and Reporting

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Department shall maintain the
				  following records:
(1) Information on private
				  or public entities authorized by the Department, including:
(a) Names of entities and
				  directors;
(b) Addresses of
				  entities;
(c) Serial numbers of the
				  initial authorizations;
(d) Initial
				  authorization dates; and
(e) Dates
				  of authorization renewals; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.08 - Overdose Response Program › Section 10.47.08.10 - General Provisions

Current through Register Vol. 51, No. 14, July 12, 2024
A. Waiver
				  of Fees. The Department may waive any fee required under this
				  chapter.
B. Discipline of a Health
				  Care Provider. A health care provider who prescribes or dispenses naloxone to
				  an individual in good faith, may not be subject to any disciplinary action
				  under Health Occupations Article, Annotated Code of Maryland, solely for the
				  act of prescribing or dispensing naloxone to the individual.
C. A cause of action may not arise against
				  any health care provider with prescribing authority, or pharmacist for any act
				  or omission when prescribing or dispensing naloxone and the necessary
				  paraphernalia for the administration of naloxone to an individual in good faith
				  under Health General Article, § 13-3108, Annotated Code of
				  Maryland.
D. An individual who
				  administers naloxone to an individual who is or in good faith is believed to be
				  experiencing an opioid overdose shall have immunity from liability under Courts
				  and Judicial Proceedings Article, §§
										5-603
				  and
				  5-629,
				  Annotated Code of Maryland.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter:
A.
				  Defines the emergency medical treatment and the limitations on this treatment
				  paid for by the Department for the victims of child abuse and
				  neglect;
B. Defines provider
				  license requirements and conditions for participation, payment, and
				  reimbursement provisions; and
C.
				  Establishes appeal procedures.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Abuse" means:
(a) The physical or mental injury of a child
				  by any parent or other person who has permanent or temporary care or custody or
				  responsibility for supervision of a child, or by any household or family
				  member, under circumstances that indicate that the child's health or welfare is
				  harmed or at substantial risk of being harmed; or
(b) Sexual abuse of a child, whether physical
				  injuries are sustained or not.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.03 - License Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  doctor of medicine shall be licensed and legally authorized to practice
				  medicine and surgery in Maryland.
B. A hospital shall be licensed by the
				  Department as a hospital, pursuant to Hospital and Related Institutions
				  subtitle, Health-General Article, Title 19, Subtitle 3, Annotated Code of
				  Maryland, and shall obtain other licenses as may be required by applicable
				  State and local laws.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.04 - Conditions for Participation

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  To be reimbursed by the Program, the provider shall:
(1) Accept payment by the Program as payment
				  in full for the services rendered to an eligible child and make no additional
				  charge to any person for covered services;
(2) Agree that if the Program denies payment
				  or requests repayment on the basis that an otherwise covered service was not
				  medically necessary, the provider may not seek payment for that service from
				  the child or child's parent or guardian;
(3) Provide services without regard to race,
				  creed, color, sex, national origin, marital status, or physical or mental
				  handicap;
(4) Maintain records for
				  a minimum of 5 years which are sufficient in detail to support the invoices
				  submitted for payment and make these records available, upon request, to the
				  Department or its designee;
(5)
				  Examine or treat any child to determine the nature and extent of any injury as
				  a result of abuse or neglect to the child if the child is brought to the
				  provider:
(a) In accordance with a court
				  order;
(b) By a police officer who
				  states that the police officer believes the child is an abused child;
				  or
(c) By a representative of a
				  local department of social services who states that the representative believes
				  the child is an abused or neglected child.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.05 - Covered Services

Current through Register Vol. 51, No. 14, July 12, 2024
The Program covers emergency medical treatment rendered to
					 children who are alleged victims of abuse or neglect. This treatment
					 includes:
A. Medical or surgical care
				  rendered by a physician or health care institution; and
B. Diagnostic tests.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 48 - CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM › Chapter 10.48.01 - Services › Section 10.48.01.06 - Limitations

Current through Register Vol. 51, No. 14, July 12, 2024
The Program does not cover the following:
A. Nonemergency outpatient
				  treatment;
B. Periodic nonemergency
				  health care;
C. Services which are
				  investigational or experimental; or
D. Services related to the assessment and
				  treatment of mental injury.